Лучшие больницы для «Arthrodesis Surgery» в Хайдарабад, Индия

The total cost of arthrodesis surgery depends primarily on which joint is being fused, the complexity of fixation (number of spinal levels, implant type, whether biologic bone graft augmentation such as rhBMP-2 is used), and the tier of hospital selected. As a comprehensive guide: in India, a single peripheral joint fusion (ankle, wrist, subtalar, or small foot/hand joints) at a JCI- or NABH-accredited hospital typically costs USD 3,500–7,500 all-inclusive (surgery, implants, anaesthesia, 3–5 days hospital stay, physiotherapy, and standard investigations). A single-level lumbar or cervical spinal fusion ranges from USD 6,000–12,000 in India. In the UAE (Dubai or Abu Dhabi) at a JCI- or DHA-licensed centre, the same peripheral joint arthrodesis ranges from USD 8,000–14,000, and single-level spinal fusion from USD 15,000–25,000. Multi-level spinal fusions or revision arthrodesis procedures carry higher costs in both destinations and are individually quoted after a thorough case review by GAF Healthcare's partner surgeons. India offers cost savings of 50–65% compared with the UAE and 70–80% compared with the United Kingdom, United States, or Australia for equivalent procedures. All GAF Healthcare packages include pre-operative consultations, surgery, hospital accommodation, standard medications, physiotherapy, and post-discharge follow-up visits; international flights, personal accommodation, and travel insurance are arranged separately.

The minimum safe in-country stay before international air travel depends on which joint has been fused. For upper-limb fusions (wrist, thumb CMC, finger interphalangeal joints), fit-to-fly clearance is typically granted at 3–4 weeks post-operatively, provided wound healing is confirmed and the patient can manage the flight in a splint or cast. For ankle, subtalar, or midfoot fusions, a minimum of 5–6 weeks in-country is recommended; patients remain non-weight-bearing in a cast for the first 6 weeks, and the immobility and dependent limb position during a long-haul flight significantly elevate DVT risk until the early healing phase is established. For single-level lumbar or cervical spinal fusion, most surgeons clear patients for long-haul flight at 5–7 weeks, after a check X-ray confirms satisfactory implant position and early bridging callus, and provided there are no wound complications. Multi-level spinal fusions typically require 7–8 weeks minimum. Critically, fit-to-fly clearance is made on an individual basis by the operating surgeon and is not granted automatically at a fixed time point — patients with diabetes, obesity, peripheral vascular disease, or prior DVT require duplex ultrasound DVT screening before flight approval. GAF Healthcare schedules the fit-to-fly surgical review, arranges the required imaging, and assists with booking flexible return flights to accommodate the actual clearance date. All patients are provided with written flight instructions including compression stocking grade, hydration advice, in-seat lower-limb exercises, and LMWH injection protocol for the flight day.

The overall clinical success rate of arthrodesis surgery — defined as achieving solid osseous fusion, clinically significant pain relief (VAS improvement ≥4 points or AOFAS/ODI score improvement ≥40%), and patient satisfaction — ranges from 85–95% across all joint types in the published peer-reviewed literature. Success rates are highest for first metatarsophalangeal (MTP) arthrodesis (92–97% fusion rate), ankle arthrodesis performed arthroscopically at high-volume centres (90–97%), and single-level lumbar interbody fusion with pedicle screw fixation (85–95% fusion rate, 70–80% satisfactory functional outcome). Non-union — the principal mode of failure — occurs in 5–10% of primary fusions in standard-risk patients. This rises to 15–25% in high-risk populations: active smokers (nicotine impairs osteoblastic activity and local microcirculation), poorly controlled diabetics (HbA1c > 9%), patients with severe osteoporosis (T-score < −3.5), and revision surgery cases. GAF Healthcare's partner hospitals are selected on the basis of audited outcome data: only centres performing a minimum of 150 arthrodesis procedures annually with documented fusion rates at or above national registry benchmarks are included in the network. Intraoperative technologies including robotic guidance (Mazor X, ROSA Spine), 3D navigation, and the use of validated biologic augments (rhBMP-2, BMAC) at these centres contribute to above-average fusion rates. Patients are counselled that while pain relief is the primary outcome goal, arthrodesis permanently eliminates motion at the fused joint; functional satisfaction is highest when patient expectations are accurately set through thorough pre-operative counselling.